nodes	percent_of_prediction	percent_of_DWPC	metapath
Piperacillin—Malnutrition—Fludarabine—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Piperacillin—Pancytopenia—Bleomycin—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Piperacillin—Liver disorder—Methotrexate—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Piperacillin—Hypokalaemia—Carmustine—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Piperacillin—Muscular weakness—Carmustine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Piperacillin—Oedema—Teniposide—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Piperacillin—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Piperacillin—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Piperacillin—Anaemia—Fludarabine—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Piperacillin—Stomatitis—Bleomycin—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Piperacillin—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Piperacillin—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Piperacillin—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Piperacillin—Hyperhidrosis—Teniposide—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Piperacillin—Leukopenia—Fludarabine—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Piperacillin—Muscular weakness—Vincristine—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Piperacillin—Pruritus—Mechlorethamine—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Piperacillin—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Piperacillin—Pancytopenia—Carmustine—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Piperacillin—Alanine aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Piperacillin—Hypotension—Teniposide—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Piperacillin—Convulsion—Fludarabine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Piperacillin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Piperacillin—Neutropenia—Carmustine—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Piperacillin—Arthralgia—Fludarabine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Piperacillin—Myalgia—Fludarabine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Piperacillin—Haemoglobin—Bleomycin—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Piperacillin—Haemorrhage—Bleomycin—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Piperacillin—Pancytopenia—Vincristine—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Piperacillin—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Piperacillin—Neutropenia—Vincristine—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Piperacillin—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Piperacillin—Oedema—Fludarabine—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Piperacillin—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Piperacillin—Renal failure—Carmustine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Piperacillin—Vomiting—Mechlorethamine—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Piperacillin—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Piperacillin—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Piperacillin—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Piperacillin—Stomatitis—Carmustine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Piperacillin—Rash—Mechlorethamine—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Piperacillin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Piperacillin—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Piperacillin—Flushing—Bleomycin—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Piperacillin—Stomatitis—Vincristine—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Piperacillin—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Piperacillin—Chills—Bleomycin—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Piperacillin—Bone disorder—Methotrexate—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Piperacillin—Renal failure—Mitoxantrone—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Piperacillin—Nausea—Mechlorethamine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Piperacillin—Hyperbilirubinaemia—Methotrexate—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Piperacillin—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Piperacillin—Jaundice—Mitoxantrone—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Piperacillin—Haemoglobin—Carmustine—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Piperacillin—Urticaria—Teniposide—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Piperacillin—Haemorrhage—Carmustine—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Piperacillin—Body temperature increased—Teniposide—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Piperacillin—Abdominal pain—Teniposide—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Piperacillin—Erythema—Bleomycin—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Piperacillin—Hallucination—Carmustine—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Piperacillin—Dyspepsia—Fludarabine—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Piperacillin—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Piperacillin—Fatigue—Fludarabine—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Piperacillin—Hallucination—Vincristine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Piperacillin—Pain—Fludarabine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Piperacillin—Constipation—Fludarabine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Piperacillin—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Piperacillin—Urethral disorder—Vincristine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Piperacillin—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Piperacillin—Hypersensitivity—Teniposide—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Piperacillin—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Piperacillin—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Piperacillin—Flushing—Carmustine—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Piperacillin—Anaemia—Bleomycin—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Piperacillin—Asthenia—Teniposide—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Piperacillin—Pruritus—Teniposide—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Piperacillin—Leukopenia—Bleomycin—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Piperacillin—Body temperature increased—Fludarabine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Piperacillin—Malnutrition—Carmustine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Piperacillin—Erythema—Carmustine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Piperacillin—Angiopathy—Vincristine—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Piperacillin—Diarrhoea—Teniposide—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Piperacillin—Myalgia—Bleomycin—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Piperacillin—Chills—Mitoxantrone—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Piperacillin—Ecchymosis—Methotrexate—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Piperacillin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Piperacillin—Oedema—Bleomycin—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Piperacillin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Piperacillin—Erythema—Mitoxantrone—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Piperacillin—Anaemia—Carmustine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Piperacillin—Vomiting—Teniposide—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Piperacillin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Piperacillin—Asthenia—Fludarabine—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Piperacillin—Rash—Teniposide—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Piperacillin—Dermatitis—Teniposide—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Piperacillin—Headache—Teniposide—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Piperacillin—Pruritus—Fludarabine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Piperacillin—Leukopenia—Carmustine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Piperacillin—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Piperacillin—Anaemia—Vincristine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Piperacillin—Hypotension—Bleomycin—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Piperacillin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Piperacillin—Convulsion—Carmustine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Piperacillin—Nausea—Teniposide—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Piperacillin—Anaemia—Mitoxantrone—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Piperacillin—Leukopenia—Vincristine—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Piperacillin—Myalgia—Carmustine—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Piperacillin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Piperacillin—Convulsion—Vincristine—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Piperacillin—Oedema—Carmustine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Piperacillin—Myalgia—Vincristine—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Piperacillin—Vomiting—Fludarabine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Piperacillin—Convulsion—Mitoxantrone—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Piperacillin—Rash—Fludarabine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Piperacillin—Dermatitis—Fludarabine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Piperacillin—Pain—Bleomycin—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Piperacillin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Piperacillin—Headache—Fludarabine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Piperacillin—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Piperacillin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Piperacillin—Myalgia—Mitoxantrone—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Piperacillin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Piperacillin—Oedema—Vincristine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Piperacillin—Nervous system disorder—Vincristine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Piperacillin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Piperacillin—Hypotension—Carmustine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Piperacillin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Piperacillin—Oedema—Mitoxantrone—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Piperacillin—Nausea—Fludarabine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Piperacillin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Piperacillin—Shock—Mitoxantrone—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Piperacillin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Piperacillin—Urticaria—Bleomycin—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Piperacillin—Body temperature increased—Bleomycin—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Piperacillin—Insomnia—Carmustine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Piperacillin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Piperacillin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Piperacillin—Hypotension—Vincristine—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Piperacillin—Hypotension—Mitoxantrone—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Piperacillin—Insomnia—Vincristine—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Piperacillin—Pain—Carmustine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Piperacillin—Constipation—Carmustine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Piperacillin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Piperacillin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Piperacillin—Fatigue—Vincristine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Piperacillin—Asthenia—Bleomycin—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Piperacillin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Piperacillin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Piperacillin—Constipation—Vincristine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Piperacillin—Pain—Vincristine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Piperacillin—Pruritus—Bleomycin—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Piperacillin—Eosinophilia—Methotrexate—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Piperacillin—Fatigue—Mitoxantrone—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Piperacillin—Pain—Mitoxantrone—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Piperacillin—Constipation—Mitoxantrone—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Piperacillin—Abdominal pain—Carmustine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Piperacillin—Body temperature increased—Carmustine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Piperacillin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Piperacillin—Pancytopenia—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Piperacillin—Neutropenia—Methotrexate—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Piperacillin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Piperacillin—Body temperature increased—Vincristine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Piperacillin—Abdominal pain—Vincristine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Piperacillin—Urticaria—Mitoxantrone—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Piperacillin—Hypersensitivity—Carmustine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Piperacillin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Piperacillin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Piperacillin—Vomiting—Bleomycin—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Piperacillin—Infestation—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Piperacillin—Infestation NOS—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Piperacillin—Rash—Bleomycin—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Piperacillin—Dermatitis—Bleomycin—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Piperacillin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Piperacillin—Asthenia—Carmustine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Piperacillin—Renal failure—Methotrexate—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Piperacillin—Stomatitis—Methotrexate—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Piperacillin—Hypersensitivity—Vincristine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Piperacillin—Epistaxis—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Piperacillin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Piperacillin—Asthenia—Vincristine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Piperacillin—Diarrhoea—Carmustine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Piperacillin—Nausea—Bleomycin—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Piperacillin—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Piperacillin—Asthenia—Mitoxantrone—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Piperacillin—Dizziness—Carmustine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Piperacillin—Haemoglobin—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Piperacillin—Diarrhoea—Vincristine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Piperacillin—Haemorrhage—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Piperacillin—Hepatitis—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Piperacillin—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Piperacillin—Urethral disorder—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Piperacillin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Piperacillin—Vomiting—Carmustine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Piperacillin—Dizziness—Vincristine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Piperacillin—Rash—Carmustine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Piperacillin—Dermatitis—Carmustine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Piperacillin—Headache—Carmustine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Piperacillin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Piperacillin—Vomiting—Vincristine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Piperacillin—Rash—Vincristine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Piperacillin—Dermatitis—Vincristine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Piperacillin—Headache—Vincristine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Piperacillin—Nausea—Carmustine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Piperacillin—Angiopathy—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Piperacillin—Vomiting—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Piperacillin—Immune system disorder—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Piperacillin—Rash—Mitoxantrone—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Piperacillin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Piperacillin—Chills—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Piperacillin—Headache—Mitoxantrone—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Piperacillin—Malnutrition—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Piperacillin—Erythema—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Piperacillin—Nausea—Vincristine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Piperacillin—Nausea—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Piperacillin—Anaemia—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Piperacillin—Leukopenia—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Piperacillin—Convulsion—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Piperacillin—Arthralgia—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Piperacillin—Myalgia—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Piperacillin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Piperacillin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Piperacillin—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Piperacillin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Piperacillin—Skin disorder—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Piperacillin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Piperacillin—Hypotension—Methotrexate—lymphatic system cancer	0.000982	0.000982	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000958	0.000958	CcSEcCtD
Piperacillin—Insomnia—Methotrexate—lymphatic system cancer	0.000951	0.000951	CcSEcCtD
Piperacillin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000925	0.000925	CcSEcCtD
Piperacillin—Fatigue—Methotrexate—lymphatic system cancer	0.000906	0.000906	CcSEcCtD
Piperacillin—Pain—Methotrexate—lymphatic system cancer	0.000899	0.000899	CcSEcCtD
Piperacillin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00086	0.00086	CcSEcCtD
Piperacillin—Urticaria—Methotrexate—lymphatic system cancer	0.000835	0.000835	CcSEcCtD
Piperacillin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000831	0.000831	CcSEcCtD
Piperacillin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000831	0.000831	CcSEcCtD
Piperacillin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000774	0.000774	CcSEcCtD
Piperacillin—Asthenia—Methotrexate—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Piperacillin—Pruritus—Methotrexate—lymphatic system cancer	0.000744	0.000744	CcSEcCtD
Piperacillin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000719	0.000719	CcSEcCtD
Piperacillin—Dizziness—Methotrexate—lymphatic system cancer	0.000695	0.000695	CcSEcCtD
Piperacillin—Vomiting—Methotrexate—lymphatic system cancer	0.000668	0.000668	CcSEcCtD
Piperacillin—Rash—Methotrexate—lymphatic system cancer	0.000663	0.000663	CcSEcCtD
Piperacillin—Dermatitis—Methotrexate—lymphatic system cancer	0.000662	0.000662	CcSEcCtD
Piperacillin—Headache—Methotrexate—lymphatic system cancer	0.000659	0.000659	CcSEcCtD
Piperacillin—Nausea—Methotrexate—lymphatic system cancer	0.000624	0.000624	CcSEcCtD
